Return to Perspectives
Defining Matters
July 19, 2021

Kramer Levin Advises Capstar Special Purpose Acquisition Corp. on $1.3 Billion Combination with Gelesis Inc.

On July 19, 2021, Kramer Levin client Capstar Special Purpose Acquisition Corp. (Capstar), a special purpose acquisition company sponsored by affiliates of Capstar Partners, LLC and certain private funds managed by PIMCO, announced that it had entered into a business combination agreement with Gelesis Inc. (Gelesis), a biotherapeutics company aiming to transform weight management using a proprietary biomimetic superabsorbent hydrogel technology. Upon the closing of the transaction, expected in the fourth quarter of 2021, Gelesis will become a public company listed on the New York Stock Exchange. The transaction values the combined company at an equity value of approximately $1.3 billion and includes a fully committed $100 million PIPE financing.

Related People

Related Practices

We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.